Last $93.36 USD
Change Today +1.06 / 1.15%
Volume 1.2M
CI On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

cigna corp (CI) Snapshot

Open
$92.14
Previous Close
$92.30
Day High
$93.61
Day Low
$91.95
52 Week High
07/3/14 - $94.24
52 Week Low
10/24/13 - $72.64
Market Cap
25.1B
Average Volume 10 Days
1.1M
EPS TTM
$6.91
Shares Outstanding
268.7M
EX-Date
03/10/14
P/E TM
13.5x
Dividend
$0.04
Dividend Yield
0.04%
Current Stock Chart for CIGNA CORP (CI)

cigna corp (CI) Details

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. The company's Commercial segment offers insured and self-insured customers medical, dental, behavioral health, and vision, as well as prescription drug benefit plans, health advocacy programs, and other products and services. Its Government segment offers Medicare Advantage plans to seniors in 15 states and the District of Columbia, Medicare Part D plans in all 50 states and the District of Columbia, and Medicaid plans. The company's Group Disability and Life segment provides group long-term and short-term disability insurance, group life insurance, and accident and specialty insurance. Its Global Supplemental Benefits segment offers supplemental health, life, and accident insurance products, as well as individual Medicare supplement plans that provide retirees with federally standardized Medigap-style plans. The company's Run-off Reinsurance segment reinsures guaranteed minimum death benefits and guaranteed minimum income benefits plans. Its Other Operations segment provides corporate-owned life insurance that are permanent insurance contracts sold to corporations to offer life coverage for certain employees; and operates the run-off settlement annuity business. The company distributes its products and services through insurance brokers and insurance consultants or directly to employers, unions, and other groups, as well as through the direct response television and the Internet. Cigna Corporation was founded in 1792 and is headquartered in Bloomfield, Connecticut.

36,500 Employees
Last Reported Date: 02/27/14
Founded in 1792

cigna corp (CI) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $1.0M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $504.5K
President of Cigna-Healthspring
Total Annual Compensation: $3.0M
President of U.S. Commercial Markets and Glob...
Total Annual Compensation: $583.4K
Executive Vice President and General Counsel
Total Annual Compensation: $545.1K
Compensation as of Fiscal Year 2013.

cigna corp (CI) Key Developments

Cigna and EvergreenHealth Partners Launch Collaborative Care Initiative

Cigna and EvergreenHealth Partners, or EHP, have launched a collaborative care initiative to improve patient access to health care and enhance care coordination. In places where it's been introduced, Cigna Collaborative Care is helping to improve the health of Cigna customers while holding the line on medical costs. The programs are helping to close gaps in care, such as missed health screenings or prescription refills, reducing unnecessary use of hospital emergency rooms, increasing the number of preventive health visits and improving follow-up care for people transitioning from the hospital to home.

Cigna Corporation Appoints Matthew G. Manders as President, U.S. Commercial Markets and Global Health Care Operations

On June 4, 2014, Cigna Corporation announced the appointment of Matthew G. Manders as President, U.S. Commercial Markets and Global Health Care Operations, effective as of the same day. Mr. Manders most recently served as Cigna's President, Regional and Operations beginning in November 2011.

Cigna Has Enters into Contract with AstraZeneca

Cigna has entered into a first-of-its-kind contract with AstraZeneca to help ensure that customers are given an appropriate cholesterol-lowering medication based on their treatment needs. For Cigna customers who are at increased risk for atherosclerotic cardiovascular disease (ASCVD) and need to aggressively manage their low-density lipoprotein cholesterol (LDL-C), CRESTOR (rosuvastatin calcium), a brand-name, cholesterol-lowering drug manufactured by AstraZeneca, can be prescribed and filled without requiring prior authorization. As an integrated health services company, Cigna is able to use both medical and pharmacy information in predictive risk modeling to appropriately assess a customer's overall health condition. This approach analyzes multiple clinical factors to identify customers most at risk for ASCVD related to high cholesterol. When a doctor prescribes CRESTOR, customers identified as being at higher risk will no longer be subject to 'step therapy'-where a generic alternative is tried first-and can have their prescriptions for CRESTOR filled immediately.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CI:US $93.36 USD +1.06

CI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aflac Inc $62.66 USD +0.24
Ameriprise Financial Inc $121.06 USD +0.79
Humana Inc $127.40 USD +0.32
Sun Life Financial Inc C$39.80 CAD -0.16
Hartford Financial Services Group Inc/The $36.37 USD +0.17
View Industry Companies
 

Industry Analysis

CI

Industry Average

Valuation CI Industry Range
Price/Earnings 13.5x
Price/Sales 0.8x
Price/Book 2.4x
Price/Cash Flow 12.9x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CIGNA CORP, please visit www.cigna.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.